Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015.

Clinical and experimental hepatology

, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Pawłowska M, Simon K, Tomasiewicz K, Małkowski P.
PMID: 28856255
Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16.

No abstract available.

Cite
, Halota W, Flisiak R, et al. Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol. 2015;1(3):97-104doi: 10.5114/ceh.2015.55566.
, Halota, W., Flisiak, R., Boroń-Kaczmarska, A., Juszczyk, J., Pawłowska, M., Simon, K., Tomasiewicz, K., & Małkowski, P. (2015). Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clinical and experimental hepatology, 1(3), 97-104. https://doi.org/10.5114/ceh.2015.55566
, et al. "Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015." Clinical and experimental hepatology vol. 1,3 (2015): 97-104. doi: https://doi.org/10.5114/ceh.2015.55566
, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Pawłowska M, Simon K, Tomasiewicz K, Małkowski P. Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16. PMID: 28856255; PMCID: PMC5497415.
Copy Download .nbib Format: NLM
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study.

Clinical and experimental hepatology

Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K.
PMID: 28856278
Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28.

THE AIM OF THE STUDY: Was to analyze the efficacy achieved with regimens available for chronic hepatitis C (CHC) in Poland between 2013 and 2016.MATERIAL AND METHODS: Data were collected from 29 centers and included 6786 patients with available...

Cite
Flisiak R, Pogorzelska J, Berak H, et al. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016;2(4):138-143doi: 10.5114/ceh.2016.63870.
Flisiak, R., Pogorzelska, J., Berak, H., Horban, A., Orłowska, I., Simon, K., Tuchendler, E., Madej, G., Piekarska, A., Jabłkowski, M., Deroń, Z., Mazur, W., Kaczmarczyk, M., Janczewska, E., Pisula, A., Smykał, J., Nowak, K., Matukiewicz, M., Halota, W., Wernik, J., Sikorska, K., Mozer-Lisewska, I., Rozpłochowski, B., Garlicki, A., Tomasiewicz, K., Krzowska-Firych, J., Baka-Ćwierz, B., Kryczka, W., Zarębska-Michaluk, D., Olszok, I., Boroń-Kaczmarska, A., Sobala-Szczygieł, B., Szlauer, B., Korcz-Ondrzejek, B., Sieklucki, J., Pleśniak, R., Ruszała, A., Postawa-Kłosińska, B., Citko, J., Lachowicz-Wawrzyniak, A., Musialik, J., Jezierska, E., Dobracki, W., Dobracka, B., Hałubiec, J., Krygier, R., Strokowska, A., Chomczyk, W., & Witczak-Malinowska, K. (2016). Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clinical and experimental hepatology, 2(4), 138-143. https://doi.org/10.5114/ceh.2016.63870
Flisiak, Robert, et al. "Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study." Clinical and experimental hepatology vol. 2,4 (2016): 138-143. doi: https://doi.org/10.5114/ceh.2016.63870
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28. PMID: 28856278; PMCID: PMC5497429.
Copy Download .nbib Format: NLM
Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients.

Clinical and experimental hepatology

Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, Boroń-Kaczmarska A.
PMID: 30603671
Clin Exp Hepatol. 2018 Dec;4(4):240-246. doi: 10.5114/ceh.2018.80125. Epub 2018 Dec 03.

AIM OF THE STUDY: To assess the performance of Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores' kinetics during hospitalization in predicting in-hospital mortality in patients with liver cirrhosis.MATERIAL AND METHODS: One hundred and seventy-four cases of...

Cite
Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, et al. Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients. Clin Exp Hepatol. 2018;4(4):240-246doi: 10.5114/ceh.2018.80125.
Piotrowski, D., Sączewska-Piotrowska, A., Jaroszewicz, J., & Boroń-Kaczmarska, A. (2018). Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients. Clinical and experimental hepatology, 4(4), 240-246. https://doi.org/10.5114/ceh.2018.80125
Piotrowski, Damian, et al. "Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients." Clinical and experimental hepatology vol. 4,4 (2018): 240-246. doi: https://doi.org/10.5114/ceh.2018.80125
Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, Boroń-Kaczmarska A. Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients. Clin Exp Hepatol. 2018 Dec;4(4):240-246. doi: 10.5114/ceh.2018.80125. Epub 2018 Dec 03. PMID: 30603671; PMCID: PMC6311743.
Copy Download .nbib Format: NLM
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016.

Clinical and experimental hepatology

, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Małkowski P, Pawłowska M, Simon K, Tomasiewicz K.
PMID: 28856269
Clin Exp Hepatol. 2016 Jun;2(2):27-33. doi: 10.5114/ceh.2016.59099. Epub 2016 Apr 07.

No abstract available.

Cite
, Halota W, Flisiak R, et al. Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016. Clin Exp Hepatol. 2016;2(2):27-33doi: 10.5114/ceh.2016.59099.
, Halota, W., Flisiak, R., Boroń-Kaczmarska, A., Juszczyk, J., Małkowski, P., Pawłowska, M., Simon, K., & Tomasiewicz, K. (2016). Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016. Clinical and experimental hepatology, 2(2), 27-33. https://doi.org/10.5114/ceh.2016.59099
, et al. "Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016." Clinical and experimental hepatology vol. 2,2 (2016): 27-33. doi: https://doi.org/10.5114/ceh.2016.59099
, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Małkowski P, Pawłowska M, Simon K, Tomasiewicz K. Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016. Clin Exp Hepatol. 2016 Jun;2(2):27-33. doi: 10.5114/ceh.2016.59099. Epub 2016 Apr 07. PMID: 28856269; PMCID: PMC5497405.
Copy Download .nbib Format: NLM
Prevalence of HCV genotypes in Poland - the EpiTer study.

Clinical and experimental hepatology

Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K.
PMID: 28856279
Clin Exp Hepatol. 2016 Dec;2(4):144-148. doi: 10.5114/ceh.2016.63871. Epub 2016 Nov 28.

THE AIM OF THE STUDY: Was to assess current prevalence of hepatitis C virus (HCV) genotypes in Poland, including their geographic distribution and changes in a given period of time.MATERIAL AND METHODS: Data were collected with questionnaires from 29...

Cite
Flisiak R, Pogorzelska J, Berak H, et al. Prevalence of HCV genotypes in Poland - the EpiTer study. Clin Exp Hepatol. 2016;2(4):144-148doi: 10.5114/ceh.2016.63871.
Flisiak, R., Pogorzelska, J., Berak, H., Horban, A., Orłowska, I., Simon, K., Tuchendler, E., Madej, G., Piekarska, A., Jabłkowski, M., Deroń, Z., Mazur, W., Kaczmarczyk, M., Janczewska, E., Pisula, A., Smykał, J., Nowak, K., Matukiewicz, M., Halota, W., Wernik, J., Sikorska, K., Mozer-Lisewska, I., Rozpłochowski, B., Garlicki, A., Tomasiewicz, K., Krzowska-Firych, J., Baka-Ćwierz, B., Kryczka, W., Zarębska-Michaluk, D., Olszok, I., Boroń-Kaczmarska, A., Sobala-Szczygieł, B., Szlauer, B., Korcz-Ondrzejek, B., Sieklucki, J., Pleśniak, R., Ruszała, A., Postawa-Kłosińska, B., Citko, J., Lachowicz-Wawrzyniak, A., Musialik, J., Jezierska, E., Dobracki, W., Dobracka, B., Hałubiec, J., Krygier, R., Strokowska, A., Chomczyk, W., & Witczak-Malinowska, K. (2016). Prevalence of HCV genotypes in Poland - the EpiTer study. Clinical and experimental hepatology, 2(4), 144-148. https://doi.org/10.5114/ceh.2016.63871
Flisiak, Robert, et al. "Prevalence of HCV genotypes in Poland - the EpiTer study." Clinical and experimental hepatology vol. 2,4 (2016): 144-148. doi: https://doi.org/10.5114/ceh.2016.63871
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Prevalence of HCV genotypes in Poland - the EpiTer study. Clin Exp Hepatol. 2016 Dec;2(4):144-148. doi: 10.5114/ceh.2016.63871. Epub 2016 Nov 28. PMID: 28856279; PMCID: PMC5497426.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries